BC Week In Review | Sep 14, 2015
Financial News

Cognition Therapeutics completes venture financing

Cognition Therapeutics Inc. , Pittsburgh, Pa.   Business: Neurology, Chemistry   Date completed: 2015-09-08   Type: Venture financing   Raised: $12 million   Investors: Golden Seeds LLC; Bios Memory; Cowtown Angels; Scale Investors; Dolby Family Ventures;...
BioCentury | May 19, 2014
Finance

Giving Chase in AD

Giving Chase in AD While the Alzheimer's disease space is littered with failed disease-modifying compounds, Chase Pharmaceuticals Corp. is taking a different tack. The company is combining undisclosed molecules with marketed AD drugs to improve...
BC Extra | May 13, 2014
Financial News

Chase secures $21 million in series B

Alzheimer's disease play Chase Pharmaceuticals Corp. (Washington, D.C.) raised an undisclosed amount in a tranched $21 million series B round led by new investor New Rhein Healthcare Investors. New investors Edmond de Rothschild Investment Partners...
BC Week In Review | Oct 28, 2013
Financial News

Swift Biosciences completes venture financing

Swift Biosciences Inc. , Ann Arbor, Mich.   Business: Diagnostic   Date completed: 10/17/13   Type: Venture financing   Raised: $7 million   Investors: Fletcher Spaght Ventures; Renaissance Venture Capital; Mercury Fund; Michigan Accelerator Fund; individual...
BC Week In Review | May 6, 2013
Company News

Harvard University sales and marketing update

The Blavatnik Family Foundation donated $50 million to the university to launch the Blavatnik Biomedical Accelerator to identify and develop early stage life science technologies at the university. The accelerator will provide grants to researchers...
BC Extra | Apr 30, 2013
Financial News

Harvard receives $50M for accelerator

The Blavatnik Family Foundation donated $50 million to Harvard University to launch the Blavatnik Biomedical Accelerator to identify and develop early stage life science technologies at the university. The accelerator will provide grants to researchers...
BioCentury | Jul 23, 2012
Emerging Company Profile

Xagenic: PCR-free diagnosis

PCR-based diagnosis of infections can delay treatment decisions by days or hours because the method relies on technical expertise and equipment not available in most point-of-care settings. Xagenic Inc. 's chip-based arrays use a non-PCR,...
BC Week In Review | Aug 15, 2011
Financial News

Technology Development Accelerator Fund financial update

Harvard University's Technology Development Accelerator Fund said it plans to raise an additional $20-$30 million. The fund, which was created in 2007, awards investigators through a grant-selection process for projects that could help bridge the...
BC Extra | Aug 12, 2011
Financial News

Harvard fund seeking to raise $20-$30M

Harvard University's Technology Development Accelerator Fund said it plans to raise an additional $20-$30 million. The fund, which was created in 2007, awards investigators through a grant-selection process for projects that could help bridge the...
BC Week In Review | Aug 1, 2011
Financial News

Cytochroma completes venture financing

Cytochroma Inc. , Markham, Ontario   Business: Metabolic, Endocrine   Date completed: 7/26/11   Type: Venture financing   Raised: C$1 million (US$1.1 million)   Investor: Investment Accelerator Fund  ...
Items per page:
1 - 10 of 13
BC Week In Review | Sep 14, 2015
Financial News

Cognition Therapeutics completes venture financing

Cognition Therapeutics Inc. , Pittsburgh, Pa.   Business: Neurology, Chemistry   Date completed: 2015-09-08   Type: Venture financing   Raised: $12 million   Investors: Golden Seeds LLC; Bios Memory; Cowtown Angels; Scale Investors; Dolby Family Ventures;...
BioCentury | May 19, 2014
Finance

Giving Chase in AD

Giving Chase in AD While the Alzheimer's disease space is littered with failed disease-modifying compounds, Chase Pharmaceuticals Corp. is taking a different tack. The company is combining undisclosed molecules with marketed AD drugs to improve...
BC Extra | May 13, 2014
Financial News

Chase secures $21 million in series B

Alzheimer's disease play Chase Pharmaceuticals Corp. (Washington, D.C.) raised an undisclosed amount in a tranched $21 million series B round led by new investor New Rhein Healthcare Investors. New investors Edmond de Rothschild Investment Partners...
BC Week In Review | Oct 28, 2013
Financial News

Swift Biosciences completes venture financing

Swift Biosciences Inc. , Ann Arbor, Mich.   Business: Diagnostic   Date completed: 10/17/13   Type: Venture financing   Raised: $7 million   Investors: Fletcher Spaght Ventures; Renaissance Venture Capital; Mercury Fund; Michigan Accelerator Fund; individual...
BC Week In Review | May 6, 2013
Company News

Harvard University sales and marketing update

The Blavatnik Family Foundation donated $50 million to the university to launch the Blavatnik Biomedical Accelerator to identify and develop early stage life science technologies at the university. The accelerator will provide grants to researchers...
BC Extra | Apr 30, 2013
Financial News

Harvard receives $50M for accelerator

The Blavatnik Family Foundation donated $50 million to Harvard University to launch the Blavatnik Biomedical Accelerator to identify and develop early stage life science technologies at the university. The accelerator will provide grants to researchers...
BioCentury | Jul 23, 2012
Emerging Company Profile

Xagenic: PCR-free diagnosis

PCR-based diagnosis of infections can delay treatment decisions by days or hours because the method relies on technical expertise and equipment not available in most point-of-care settings. Xagenic Inc. 's chip-based arrays use a non-PCR,...
BC Week In Review | Aug 15, 2011
Financial News

Technology Development Accelerator Fund financial update

Harvard University's Technology Development Accelerator Fund said it plans to raise an additional $20-$30 million. The fund, which was created in 2007, awards investigators through a grant-selection process for projects that could help bridge the...
BC Extra | Aug 12, 2011
Financial News

Harvard fund seeking to raise $20-$30M

Harvard University's Technology Development Accelerator Fund said it plans to raise an additional $20-$30 million. The fund, which was created in 2007, awards investigators through a grant-selection process for projects that could help bridge the...
BC Week In Review | Aug 1, 2011
Financial News

Cytochroma completes venture financing

Cytochroma Inc. , Markham, Ontario   Business: Metabolic, Endocrine   Date completed: 7/26/11   Type: Venture financing   Raised: C$1 million (US$1.1 million)   Investor: Investment Accelerator Fund  ...
Items per page:
1 - 10 of 13